From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves FoundationOne CDx to detect cancer biomarkers

from Healio

The FDA approved a next-generation sequencing-based in vitro diagnostic test that can detect genetic mutations in 324 genes and two genomic signatures in any solid tumor. The FDA has approved other companion diagnostics that match one test to one drug. FoundationOne CDX (Foundation Medicine Inc.) is designed to be a more extensive test that provides information about several genetic mutations that may help guide treatment of patients with cancer. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063